PEARRL
  • PEARRL Project
    • Beneficiaries
    • Partner Organisation
    • People >
      • Supervisors >
        • Prof. B. Griffin
        • Prof. M. Kuentz
        • Dr. C. Saal
        • Dr. L. Kalantzi
        • Dr. E. Kostewicz
        • Prof. C. Reppas
        • Prof. J. Dressman
        • Dr. N. Fotaki
        • Dr. R. Holm
        • Dr. M. Vertzoni
        • Dr. K. Box
        • Prof. C. O'Driscoll
      • Researchers >
        • Niklas Köhl (ESR1)
        • Felix Ditzinger (ESR 2)
        • Daniel Price (ESR 3)
        • Georgia Tsakiridou (ESR 4)
        • Sandra Jankovic (ESR 5)
        • Chara Litou (ESR 6)
        • Christina Pentafragka (ESR 7)
        • Rafael Leal Monteiro Paraiso (ESR 8)
        • Laura Henze (ESR 9)
        • Patrick O'Dwyer (ESR 10)
        • Marina Statelova (ESR 11)
        • Mariana Guimarães (ESR 12)
        • Ioannis Loisios-Konstantinidis (ESR 13)
        • Alexandra-Roxana Ilie (ESR 14)
        • Angela Effinger (ESR 15)
      • Scientific Advisory Board >
        • Prof. Carla Caramella
        • Dr. Paul Dickinson
        • Dr. Andrea Edginton
        • Dr. Susanne Keitel
        • Dr. Mehul Mehta
    • PEARRL Wiki >
      • FAQ
      • Glossary
  • Research
    • Workplan
    • WP1: Bio-enabling formulations
    • WP2: Biopharmaceutical tools
    • WP3: In silico methods
    • Results >
      • Scientific Publications
      • Conference Contributions
      • InfoPEARRLs
      • Media
  • Training
    • Local
    • Network-wide
    • PEARRL Online Learning Portal
    • Member Area
  • News
  • Events & Meetings
    • Webinar: Regulatory Science Apprentice
    • Annual Meeting 2019
    • Model Informed Drug Development Symposium 2019
    • Annual Meeting 2018
    • Regulatory Science Symposium 2018
    • Annual Meeting 2017
    • Regulatory Science Symposium 2017
    • PEARRL Calendar
    • International Conferences
  • PEARRL Project
    • Beneficiaries
    • Partner Organisation
    • People >
      • Supervisors >
        • Prof. B. Griffin
        • Prof. M. Kuentz
        • Dr. C. Saal
        • Dr. L. Kalantzi
        • Dr. E. Kostewicz
        • Prof. C. Reppas
        • Prof. J. Dressman
        • Dr. N. Fotaki
        • Dr. R. Holm
        • Dr. M. Vertzoni
        • Dr. K. Box
        • Prof. C. O'Driscoll
      • Researchers >
        • Niklas Köhl (ESR1)
        • Felix Ditzinger (ESR 2)
        • Daniel Price (ESR 3)
        • Georgia Tsakiridou (ESR 4)
        • Sandra Jankovic (ESR 5)
        • Chara Litou (ESR 6)
        • Christina Pentafragka (ESR 7)
        • Rafael Leal Monteiro Paraiso (ESR 8)
        • Laura Henze (ESR 9)
        • Patrick O'Dwyer (ESR 10)
        • Marina Statelova (ESR 11)
        • Mariana Guimarães (ESR 12)
        • Ioannis Loisios-Konstantinidis (ESR 13)
        • Alexandra-Roxana Ilie (ESR 14)
        • Angela Effinger (ESR 15)
      • Scientific Advisory Board >
        • Prof. Carla Caramella
        • Dr. Paul Dickinson
        • Dr. Andrea Edginton
        • Dr. Susanne Keitel
        • Dr. Mehul Mehta
    • PEARRL Wiki >
      • FAQ
      • Glossary
  • Research
    • Workplan
    • WP1: Bio-enabling formulations
    • WP2: Biopharmaceutical tools
    • WP3: In silico methods
    • Results >
      • Scientific Publications
      • Conference Contributions
      • InfoPEARRLs
      • Media
  • Training
    • Local
    • Network-wide
    • PEARRL Online Learning Portal
    • Member Area
  • News
  • Events & Meetings
    • Webinar: Regulatory Science Apprentice
    • Annual Meeting 2019
    • Model Informed Drug Development Symposium 2019
    • Annual Meeting 2018
    • Regulatory Science Symposium 2018
    • Annual Meeting 2017
    • Regulatory Science Symposium 2017
    • PEARRL Calendar
    • International Conferences

PEARRL ESRs on their regulatory secondment at the HPRA

2/27/2018

0 Comments

 
Written by Sandra Jankovic (ESR 5) & Laura Henze (ESR 9)
 
As part of PEARRL we had the opportunity of getting three months experience in the regulatory environment within the Health Products Regulatory Authority (HPRA) in Dublin. HPRA is the national competent authority that regulates human medicines, veterinary medicines, medical devices and other health products in Ireland. We were the second PEARRL students in the HPRA after Felix Ditzinger and Niklas Koehl, who worked at the HPRA at the beginning of this year.

Picture
During the three months we were at the HPRA, we were based in the Pharmaceutical Assessment Team. We were supported by our supervisors in our day to day work and able to join various team meetings where several pharmaceutical topics were discussed. Furthermore, we were involved in two projects, in collaboration with two Sections with the Human Products Authorisation and Registration Department: Clinical Assessment & Pharmaceutical Assessment. We analysed internal HPRA databases and presented our findings to the relevant teams.

Overall, we got an impressive insight into regulatory procedures for medicines. We were able to join, not only the internal training program of the Pharmaceutical Assessment Section focusing on interchangeable medicines, variations, renewals & clinical trial applications, but also several training courses from different departments within the HPRA such as the Veterinary Science and the Pharmacovigilance & Risk Management Departments. We were then able to implement our knowledge through the assessment of Product Information and renewals for marketing authorisations of human medicinal products.

As PEARRL brings together a multi-national network of European Pharma Industry, Academia and the Regulatory Agencies, it gives all Early Stage Researchers the opportunity to get familiar with each area and be trained on various innovative topics. The regulatory environment was a completely new world for us - during team meetings we were able to get a deeper insight into the risk-benefit evaluation involved in the pre and post-licensing activities for medicinal products and its importance in the protection of public health.

Thanks to the support of our supervisors we were able to gain a deeper understanding of the pharmaceutical regulatory activities, not only within the Irish market, but also throughout the European Regulatory framework.  Despite our short stay at the HPRA, it was a great experience and an essential piece in our future careers, perhaps as Regulatory Scientists!

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    September 2020
    June 2020
    May 2020
    March 2020
    December 2019
    July 2019
    June 2019
    May 2019
    March 2019
    February 2019
    January 2019
    December 2018
    September 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    December 2017
    November 2017
    October 2017
    September 2017
    July 2017
    June 2017
    April 2017
    January 2017
    November 2016
    October 2016
    September 2016
    July 2016
    May 2016
    March 2016
    February 2016

    Categories

    All
    Events
    Milestone
    People
    Research

    RSS Feed

Picture
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 674909.
Disclaimer | Member Area
© accelopment Schweiz AG 2019. ALL RIGHTS RESERVED.